Overestimation of SARS-CoV-2 household transmission in settings of high community transmission: insights from an informal settlement community in Salvador, Brazil

Juan P Aguilar Ticona,Nivison Nery,Matt Hitchings,Emilia M M Andrade Belitardo,Mariam O Fofana,Murilo Dorión,Renato Victoriano,Jaqueline S Cruz,Juliet Oliveira Santana,Laise Eduarda Paixão de Moraes,Cristiane W Cardoso,Guilherme S Ribeiro,Mitermayer G Reis,Ricardo Khouri,Federico Costa,Albert I Ko,Derek A T Cummings
DOI: https://doi.org/10.1093/ofid/ofae065
2024-02-05
Open Forum Infectious Diseases
Abstract:Abstract Background The SARS-CoV-2 Omicron variant has spread globally. However, the contribution of community versus household transmission to the overall risk of infection remains unclear. Methods Between November 2021, and March 2022, we conducted an active case-finding study in an urban informal settlement with biweekly visits across 1174 households with 3364 residents. Individuals displaying COVID-19-related symptoms were identified, interviewed along with household contacts, and defined as index and secondary cases based on RT-PCR and symptom onset. Results In 61 households, we detected a total of 94 RT-PCR-positive cases. Out of 69 sequenced samples, 67 cases (97.1%) were attributed to the Omicron BA.1* variant. Among 35 of their households, the secondary attack rate was 50.0% (95%CI 37.0–63.0%). Women (RR = 1.6; 95%CI = 0.9–2.7), older individuals (median difference = 15; 95%CI = 2–21), and those reporting symptoms (RR = 1.73; 95% CI = 1.0–3.0) had a significantly increased risk for SARS-CoV-2 secondary infection. Genomic analysis revealed substantial acquisition of viruses from the community even among households with other SARS-CoV-2 infections. After excluding community acquisition, we estimated a household secondary attack rate of 24.2% (95%CI 11.9–40.9%). Conclusions These findings underscore the ongoing risk of community acquisition of SARS-CoV-2 among households with current infections. The observed high attack rate necessitates swift booster vaccination, rapid testing availability, and therapeutic options to mitigate COVID-19's severe outcomes.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?